Incremental Hemodialysis: The TwoPlus Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 350 participants.

Also called NCT05828823

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 350 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05828823
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05828823. Randomized; no masking; primary purpose treatment. Start 2024-02-26 (actual); primary completion 2030-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Incremental Hemodialysis: The TwoPlus Trial
Condition
End-Stage Kidney Disease
Intervention (Device)
Hemodialysis twice weekly
Intervention (Other)
Hemodialysis thrice weekly
Lead sponsor
Wake Forest University Health Sciences (class: other)
Collaborator
Patient-Centered Outcomes Research Institute (class: other)

Record details

Record id
cardio:ct-nct05828823
Content hash
f4fc2ae30a76ff2740a3c4384e7d0a1a133d9e0a31228fb81da1eef95d7cc615